Bibliographic Citation
| - Scherpereel A., Antonia S., Bautista Y., Grossi F., Kowalski D., Zalcman G., Nowak A.K., Fujimoto N., Peters S., Tsao A.S., Mansfield A.S., Popat S., Sun X., Lawrance R., Zhang X., Daumont M.J., Bennett B., McKenna M., Baas P.. First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743.2022.
|